Literature DB >> 978726

Crystal structure of bovine trypsinogen at 1-8 A resolution. I. Data collection, application of patterson search techniques and preliminary structural interpretation.

W Bode, H Fehlhammer, R Huber.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 978726     DOI： 10.1016/0022-2836(76)90089-9

Source DB:  PubMed          Journal:  J Mol Biol        ISSN： 0022-2836            Impact factor:   5.469


× No keyword cloud information.
  12 in total

1.  The structure of the human betaII-tryptase tetramer: fo(u)r better or worse.

Authors:  C P Sommerhoff; W Bode; P J Pereira; M T Stubbs; J Stürzebecher; G P Piechottka; G Matschiner; A Bergner
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

2.  Modeling studies of the change in conformation required for cleavage of limited proteolytic sites.

Authors:  S J Hubbard; F Eisenmenger; J M Thornton
Journal:  Protein Sci       Date:  1994-05       Impact factor: 6.725

3.  Lysine 156 promotes the anomalous proenzyme activity of tPA: X-ray crystal structure of single-chain human tPA.

Authors:  M Renatus; R A Engh; M T Stubbs; R Huber; S Fischer; U Kohnert; W Bode
Journal:  EMBO J       Date:  1997-08-15       Impact factor: 11.598

Review 4.  [Activation, activity and inhibition of bovine trypsin].

Authors:  W Bode
Journal:  Naturwissenschaften       Date:  1979-05

5.  Structural basis of profactor D activation: from a highly flexible zymogen to a novel self-inhibited serine protease, complement factor D.

Authors:  H Jing; K J Macon; D Moore; L J DeLucas; J E Volanakis; S V Narayana
Journal:  EMBO J       Date:  1999-02-15       Impact factor: 11.598

6.  Structural basis for complement factor I control and its disease-associated sequence polymorphisms.

Authors:  Pietro Roversi; Steven Johnson; Joseph J E Caesar; Florence McLean; Kirstin J Leath; Stefanos A Tsiftsoglou; B Paul Morgan; Claire L Harris; Robert B Sim; Susan M Lea
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-18       Impact factor: 11.205

7.  Cathepsin L inactivates human trypsinogen, whereas cathepsin L-deletion reduces the severity of pancreatitis in mice.

Authors:  Thomas Wartmann; Julia Mayerle; Thilo Kähne; Miklós Sahin-Tóth; Manuel Ruthenbürger; Rainer Matthias; Anne Kruse; Thomas Reinheckel; Christoph Peters; F Ulrich Weiss; Matthias Sendler; Hans Lippert; Hans-Ulrich Schulz; Ali Aghdassi; Annegret Dummer; Steffen Teller; Walter Halangk; Markus M Lerch
Journal:  Gastroenterology       Date:  2009-11-10       Impact factor: 22.682

8.  Prediction of the three-dimensional structures of the nerve growth factor and epidermal growth factor binding proteins (kallikreins) and an hypothetical structure of the high molecular weight complex of epidermal growth factor with its binding protein.

Authors:  B Bax; M Blaber; G Ferguson; M J Sternberg; P H Walls
Journal:  Protein Sci       Date:  1993-08       Impact factor: 6.725

Review 9.  Methods of probing the interactions between small molecules and disordered proteins.

Authors:  Gabriella T Heller; Francesco A Aprile; Michele Vendruscolo
Journal:  Cell Mol Life Sci       Date:  2017-06-19       Impact factor: 9.261

10.  Cathepsin B cleavage of the trypsinogen activation peptide.

Authors:  Niels Teich; Hans Bödeker; Volker Keim
Journal:  BMC Gastroenterol       Date:  2002-06-27       Impact factor: 3.067
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.